<DOC>
	<DOC>NCT02145104</DOC>
	<brief_summary>The purpose of this study is to evaluate of efficacy and safety of cilinidipine plus valsartan and valsartan alone in patients with essential hypertension inadequately controlled on valsartan monotherapy</brief_summary>
	<brief_title>Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Cilnidipine</mesh_term>
	<criteria>essential hypertension patients whose blood pressure is not controlled before the study (sDBP≥90mmHg for drugtreated patients, sDBP≥95mmHg for drugnaive patients) sSBP≥80mmHg after 4weeks of valsartan 160mg treatment has a history of hypersensitivity to dihydropyridines or angiotensin II receptor blockers</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>